ARCHIVES

Adding Aresenic To Therapy Improves APL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007